SS

Suresh Subramanian

Active Director Partner DIN 08796754
DIN 08796754 First appointment Feb 2012 Primary industry Travel and Hospitality
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Feb 2012
Shareholding value •••• Premium profile

About Suresh Subramanian

Data last updated:

Suresh Subramanian is a Partner at Ernst & Young Llp (since 2022) and Designated Partner at Tychai Business Consultants Llp (since 2020). The companies operate in Travel and Hospitality, Business Services and Chemicals. The largest current company by reported revenue is Ernst & Young Llp at ₹11,012 Cr (FY 2023). Earlier, Suresh Subramanian was a Director at Pfizer Animal Pharma Private Limited (2012).

DIN 08796754
Primary Designation Partner
Industry Travel and Hospitality
First Appointment 10 Feb 2012
Oldest Company Age 13 yrs
Largest company Ernst & Young Llp · ₹11,012 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner01 Jun 20222013₹11,012 Cr (FY 2023)Active
Designated Partner17 Jul 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pfizer Animal Pharma Private Limited U24233MH2012PTC226716
Director10 Feb 20122012Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tychai Business Consultants Llp
Ernst & Young Llp
Pfizer Animal Pharma Private Limited
Premium access

Shareholding and investment profile for Suresh Subramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Subramanian

Suresh Subramanian currently holds 2 directorships: Ernst & Young Llp (Partner, since 01 Jun 2022, revenue ₹11,012 Cr (FY 2023)); Tychai Business Consultants Llp (Designated Partner, since 17 Jul 2020).

Suresh Subramanian was first appointed on 10 Feb 2012 as Director at Pfizer Animal Pharma Private Limited. The most recent appointment on record is 01 Jun 2022 at Ernst & Young Llp.

Suresh Subramanian held 1 earlier board appointment: Pfizer Animal Pharma Private Limited (Director, 10 Feb 2012 to 10 Dec 2012).

The current boards of Suresh Subramanian's companies include Aashish Behram Kasad (Ernst & Young Llp), Adithya Janardhan Bhat (Ernst & Young Llp), Ajit Pai (Ernst & Young Llp), Amar Shankar (Ernst & Young Llp), Amit Banshidhar Bothra (Ernst & Young Llp), Amit Bhailal Maru (Ernst & Young Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available